Article 01 Aug 2024 Health Canada's Proposed Regulatory Amendments To Address Health Product Shortages Canada Healthcare
Article 01 Jul 2024 Supreme Court Of Canada Dismisses Apotex And Pharmascience's Applications For Leave To Appeal Paliperidone Inducing Infringement Decisions Canada Healthcare
Article 19 Jun 2024 Supreme Court Of Canada Dismisses Apotex's Application For Leave To Appeal Macitentan Inducing Infringement Decision Canada IP
Article 07 May 2024 Federal Court Finds Patent For Concentrated Methotrexate Solutions Obvious Canada IP
Article 05 Mar 2024 FCA Upholds Inducement Of Infringement Findings Relating To Paliperidone Palmitate Canada IP
Article 27 Nov 2023 Federal Court Of Appeal And Federal Court Release Three Decisions Relating To Macitentan (Janssen's OPSUMIT) Canada IP
Article 01 Aug 2023 Minister Of Health Reasonable In Deciding Patent For Janssen's STELARA Was Ineligible For Listing Against SNDSs Canada IP
Article 11 May 2023 FCA Finds Teva Would Directly Infringe And Induce Infringement Of Janssen's Paliperidone Palmitate Patent Canada IP